Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹564.70
Market cap: ₹1,131 Cr
Revenue (annual): ₹671.0 Cr
Net profit (annual): ₹87.89 Cr
P/E (TTM): 11.7×Sector 47.4×
Promoter holding: 49.78%+0.00% QoQ
FII holding: 4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 3 Board Meeting Date 2 Results Correction 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Aug 2026 12:37 IST BSE

Board Meeting Date

Lincoln Pharmaceuticals Board Meeting Date

Lincoln Pharmaceuticals Ltd will hold a board meeting on August 13, 2026. The board will consider and approve unaudited financial results for the quarter ended June 2026.

Read the filing ↗

18 May 2026 14:36 IST BSE

Board Meeting Date

Lincoln Pharmaceuticals Board Meeting Date

Lincoln Pharmaceuticals scheduled a May 28 board meeting to approve annual financial results and dividend recommendations. This advance notice signals upcoming performance and payout disclosures.

Read the filing ↗